SV2010003684A - Capsula para la prevencion de enfermedades cardiovasculares - Google Patents

Capsula para la prevencion de enfermedades cardiovasculares

Info

Publication number: SV2010003684A
Authority: SV; El Salvador
Prior art keywords: prevention; cardiovascular diseases; capsule; covered; overheaded
Prior art date: 2008-03-28

Application number

SV2010003684A

Other languages

English (en)

Spanish (es)

Inventor

Marta Guerrero

Anna Orriols

Pablo Martin

Manuel Raga

Original Assignee

Ferrer Int

Fundacion Ct Nac Inv Cardio Carlos Iii Lar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-28

Filing date

2010-09-28

Publication date

2011-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40010466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2010003684(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-09-28 Application filed by Ferrer Int, Fundacion Ct Nac Inv Cardio Carlos Iii Lar filed Critical Ferrer Int

2011-03-31 Publication of SV2010003684A publication Critical patent/SV2010003684A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Biophysics (AREA)
Hematology (AREA)
Obesity (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

SV2010003684A 2008-03-28 2010-09-28 Capsula para la prevencion de enfermedades cardiovasculares SV2010003684A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP08153615		2008-03-28

Publications (1)

Publication Number	Publication Date
SV2010003684A true SV2010003684A (es)	2011-03-31

Family

ID=40010466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SV2010003684A SV2010003684A (es)	2008-03-28	2010-09-28	Capsula para la prevencion de enfermedades cardiovasculares

Country Status (34)

Country	Link
US (1)	US8753680B2 (fr)
EP (1)	EP2273985B1 (fr)
JP (1)	JP2011515445A (fr)
KR (1)	KR20110007602A (fr)
CN (1)	CN101980701A (fr)
AR (1)	AR071094A1 (fr)
AU (1)	AU2009228832A1 (fr)
BR (1)	BRPI0909254A2 (fr)
CA (1)	CA2720800C (fr)
CL (1)	CL2009000767A1 (fr)
CO (1)	CO6311069A2 (fr)
CR (1)	CR11736A (fr)
CY (1)	CY1117556T1 (fr)
DK (1)	DK2273985T3 (fr)
EC (1)	ECSP10010562A (fr)
ES (1)	ES2569553T3 (fr)
GT (1)	GT201000275A (fr)
HN (1)	HN2010001979A (fr)
HR (1)	HRP20160416T1 (fr)
HU (1)	HUE028919T2 (fr)
IL (1)	IL208455A0 (fr)
IS (1)	IS8932A (fr)
MA (1)	MA32347B1 (fr)
MX (1)	MX2010010479A (fr)
NI (1)	NI201000159A (fr)
NZ (1)	NZ588239A (fr)
PL (1)	PL2273985T3 (fr)
RU (1)	RU2477123C2 (fr)
SI (1)	SI2273985T1 (fr)
SV (1)	SV2010003684A (fr)
TW (1)	TW200944251A (fr)
UA (1)	UA99758C2 (fr)
UY (1)	UY31741A (fr)
WO (1)	WO2009118359A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR201005325A2 (tr) *	2010-06-30	2012-01-23	Bi̇lgi̇ç Mahmut	Atorvastatin ve aspirin içeren farmasötik formülasyonlar
FR2967577B1 (fr)	2010-11-18	2013-07-12	Advicenne Pharma	Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament
KR101298788B1 (ko) *	2011-03-15	2013-08-22	보령제약 주식회사	안정성이 개선된 복합제제
KR101378973B1 (ko) *	2012-04-13	2014-03-28	한미약품 주식회사	구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
KR20140030505A (ko) *	2012-08-31	2014-03-12	한미약품 주식회사	이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
CN103006612B (zh) *	2012-12-28	2014-07-02	石雷	一种赖诺普利迟释缓释片剂及其制备方法
EP2810644A1 (fr) *	2013-06-06	2014-12-10	Ferrer Internacional, S.A.	Formulation orale pour le traitement de maladies cardiovasculaires
JP6465201B2 (ja) *	2015-03-05	2019-02-06	日本電気株式会社	無線設備の故障判定方法及び移動体無線システム
BE1023011B1 (nl) *	2015-08-05	2016-11-04	Nordic Specialty Pharma Bvba	Acetylsalicylzuur tablet met onmiddellijke afgifte
ES2695503B2 (es)	2017-06-30	2020-05-08	Pharmalink S L	Formulaciones encapsuladas
KR102042626B1 (ko)	2019-06-26	2019-11-11	한미약품 주식회사	이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
EP4247354A4 (fr) *	2020-11-18	2025-02-19	Fb-Hrs, Llc	Compositions contenant du dofétilide et de la mexilétine et leurs utilisations
ES2989428T3 (es)	2022-06-30	2024-11-26	Ferrer Int	Cápsulas orales que comprenden comprimidos de atorvastatina que muestran un perfil de disolución y una biodisponibilidad adecuados
CN115671077B (zh) *	2022-11-18	2024-09-17	乐普药业股份有限公司	一种预防心脑血管疾病的复方微丸胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3739690A1 (de)	1987-11-24	1989-06-08	Hoechst Ag	Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
JP2544052B2 (ja) *	1991-12-18	1996-10-16	日本エランコ株式会社	硬質ゼラチンカプセルへの錠剤充填装置
SE9702000D0 (sv) *	1997-05-28	1997-05-28	Astra Ab	New pharmaceutical formulation
US6235311B1 (en) *	1998-03-18	2001-05-22	Bristol-Myers Squibb Company	Pharmaceutical composition containing a combination of a statin and aspirin and method
CN1216596C (zh)	2000-02-10	2005-08-31	Bpsi控股公司	丙烯酸肠溶性涂层组合物
US6576256B2 (en) *	2001-08-28	2003-06-10	The Brigham And Women's Hospital, Inc.	Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
US6669955B2 (en) *	2001-08-28	2003-12-30	Longwood Pharmaceutical Research, Inc.	Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
WO2004080488A2 (fr)	2003-03-10	2004-09-23	Bayer Healthcare Ag	Preparations combinees d'acide acetylsalycilique pour la prevention primaire de maladies cardiovasculaires
CN1822820A (zh)	2003-07-28	2006-08-23	雷迪实验室有限公司	心血管疾病的治疗和预防
US8277844B2 (en)	2003-08-20	2012-10-02	Shionogi & Co., Ltd.	Coating composition
US20070009591A1 (en)	2005-07-07	2007-01-11	Trivedi Jay S	ACE inhibitor formulation
US20070116756A1 (en) *	2005-11-23	2007-05-24	Dr. Reddy's Laboratories Limited	Stable pharmaceutical compositions
US7427414B2 (en)	2006-01-18	2008-09-23	Astron Research Limited	Modified release oral dosage form using co-polymer of polyvinyl acetate
US20080014271A1 (en) *	2006-07-13	2008-01-17	Ucb, S.A.	Novel pharmaceutical compositions comprising levetiracetam
WO2009022821A2 (fr)	2007-08-13	2009-02-19	Hanall Pharmaceutical Company. Ltd	Préparation combinée contenant un inhibiteur de hmg-coa reductase et aspirine et son procédé d'élaboration

2009
- 2009-03-25 AU AU2009228832A patent/AU2009228832A1/en not_active Abandoned
- 2009-03-25 CN CN2009801113235A patent/CN101980701A/zh active Pending
- 2009-03-25 UA UAA201011547A patent/UA99758C2/ru unknown
- 2009-03-25 MX MX2010010479A patent/MX2010010479A/es active IP Right Grant
- 2009-03-25 EP EP09724677.1A patent/EP2273985B1/fr active Active
- 2009-03-25 HU HUE09724677A patent/HUE028919T2/en unknown
- 2009-03-25 CA CA2720800A patent/CA2720800C/fr active Active
- 2009-03-25 KR KR1020107021681A patent/KR20110007602A/ko not_active Withdrawn
- 2009-03-25 SI SI200931435A patent/SI2273985T1/sl unknown
- 2009-03-25 NZ NZ588239A patent/NZ588239A/en not_active IP Right Cessation
- 2009-03-25 ES ES09724677.1T patent/ES2569553T3/es active Active
- 2009-03-25 RU RU2010144131/15A patent/RU2477123C2/ru active
- 2009-03-25 WO PCT/EP2009/053545 patent/WO2009118359A2/fr not_active Ceased
- 2009-03-25 BR BRPI0909254A patent/BRPI0909254A2/pt not_active IP Right Cessation
- 2009-03-25 JP JP2011501225A patent/JP2011515445A/ja active Pending
- 2009-03-25 HR HRP20160416TT patent/HRP20160416T1/hr unknown
- 2009-03-25 DK DK09724677.1T patent/DK2273985T3/en active
- 2009-03-25 PL PL09724677T patent/PL2273985T3/pl unknown
- 2009-03-25 US US12/934,942 patent/US8753680B2/en active Active
- 2009-03-26 TW TW098109878A patent/TW200944251A/zh unknown
- 2009-03-27 CL CL2009000767A patent/CL2009000767A1/es unknown
- 2009-03-27 AR ARP090101095A patent/AR071094A1/es not_active Application Discontinuation
- 2009-03-30 UY UY0001031741A patent/UY31741A/es unknown
2010
- 2010-09-27 NI NI201000159A patent/NI201000159A/es unknown
- 2010-09-27 GT GT201000275A patent/GT201000275A/es unknown
- 2010-09-28 SV SV2010003684A patent/SV2010003684A/es unknown
- 2010-09-29 HN HN2010001979A patent/HN2010001979A/es unknown
- 2010-10-03 IL IL208455A patent/IL208455A0/en unknown
- 2010-10-05 IS IS8932A patent/IS8932A/is unknown
- 2010-10-15 CR CR11736A patent/CR11736A/es not_active Application Discontinuation
- 2010-10-19 MA MA33268A patent/MA32347B1/fr unknown
- 2010-10-22 EC EC2010010562A patent/ECSP10010562A/es unknown
- 2010-10-28 CO CO10134210A patent/CO6311069A2/es not_active Application Discontinuation
2016
- 2016-05-13 CY CY20161100410T patent/CY1117556T1/el unknown

Also Published As

Publication number	Publication date
IS8932A (is)	2010-10-05
MA32347B1 (fr)	2011-06-01
DK2273985T3 (en)	2016-04-25
NI201000159A (es)	2011-08-02
SI2273985T1 (sl)	2016-06-30
HN2010001979A (es)	2013-07-01
HRP20160416T1 (hr)	2016-06-17
WO2009118359A3 (fr)	2010-05-06
WO2009118359A2 (fr)	2009-10-01
CA2720800C (fr)	2013-07-30
EP2273985A2 (fr)	2011-01-19
NZ588239A (en)	2011-09-30
UA99758C2 (ru)	2012-09-25
ECSP10010562A (es)	2011-04-29
JP2011515445A (ja)	2011-05-19
RU2010144131A (ru)	2012-05-10
GT201000275A (es)	2015-09-30
EP2273985B1 (fr)	2016-02-17
CY1117556T1 (el)	2017-04-26
HUE028919T2 (en)	2017-01-30
CO6311069A2 (es)	2011-08-22
CA2720800A1 (fr)	2009-10-01
TW200944251A (en)	2009-11-01
AR071094A1 (es)	2010-05-26
KR20110007602A (ko)	2011-01-24
MX2010010479A (es)	2011-02-22
AU2009228832A1 (en)	2009-10-01
PL2273985T3 (pl)	2016-08-31
US8753680B2 (en)	2014-06-17
CR11736A (es)	2011-05-11
CL2009000767A1 (es)	2009-08-14
US20110086094A1 (en)	2011-04-14
UY31741A (es)	2009-12-14
CN101980701A (zh)	2011-02-23
IL208455A0 (en)	2010-12-30
ES2569553T3 (es)	2016-05-11
BRPI0909254A2 (pt)	2017-01-10
RU2477123C2 (ru)	2013-03-10

Publication	Publication Date	Title
SV2010003684A (es)	2011-03-31	Capsula para la prevencion de enfermedades cardiovasculares
CU20130066A7 (es)	2013-09-27	Polipéptidos que se enlazan a cxcr2
BR112012032008A2 (pt)	2016-10-04	anticorpos s100a4 e usos terapêuticos do mesmo
CL2011002222A1 (es)	2012-03-23	Metodo para preparar una proteina biologica condicionalmente activa; metodo para preparar un modificador condicionalmente activo de respuesta biologica.
UY33370A (es)	2011-12-30	Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
CO7030953A2 (es)	2014-08-21	Procedimiento para producir un implante médico a partir de una aleación de magnesio
CR11819A (es)	2011-03-23	Compuestos de isoindolina 5-sustituidos
MX373666B (es)	2020-04-30	Compensador de grosor de tejido que comprende una pluralidad de capsulas.
CY1115254T1 (el)	2017-01-04	Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις
DK2254549T3 (da)	2013-12-02	Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
IT1396947B1 (it)	2012-12-20	Capsula per la preparazione di una bevanda
CL2014000163A1 (es)	2014-08-01	Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento.
WO2011136493A3 (fr)	2012-03-01	Dispositif de fixation orthodontique pour palais
EP2347974A4 (fr)	2012-11-21	Emballage à expulsion par pression et procédé de retrait de médicament à partir de celui-ci
UY32507A (es)	2010-10-29	Una dosis de ave5026 para el tratamiento de trombormbolismo venoso en pacientes con deterioro renal severo
IT1394268B1 (it)	2012-06-06	Procedimento per la realizzazione di una calzatura
GT200800178A (es)	2010-07-02	Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina
EA201170843A1 (ru)	2012-02-28	Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
HN2010000533A (es)	2013-07-08	Nuevas sales de adicion de inhibidores de la enzima de conversion de la angiotensina a acidos donadores de no, procedimiento de preparacion y las composiciones farmaceuticas que las contienen
UY34769A (es)	2013-11-29	Forma farmacéutica oral para la prevención de enfermedades vasculares, comprimido como forma farmacéutica y cápsula gelatinosa como forma farmacéutica
EA201370024A1 (ru)	2013-06-28	Композиция, содержащая шеллак и/или его соль и натрия крахмалгликолят
CL2015001621A1 (es)	2015-08-07	Proceso para la formacion de tabletas de ibuprofeno de sodio dihidratado, que comprende la formacion de tabletas en una prensa a partir de gránulos.
IT1393726B1 (it)	2012-05-08	Calzatura sportiva, particolarmente per la pratica del motociclismo
EA201291118A1 (ru)	2013-05-30	Нутрицевтические и фармацевтические композиции, покрытые оболочкой из жевательной резинки
UA36998U (uk)	2008-11-10	Комбінований засіб для лікування серцево-судинних захворювань для перорального застосування